rewrite this content using a minimum of 1000 words and keep HTML tags
Moderna, Inc. (MRNA) Analyst/Investor Day November 20, 2025 9:00 AM EST
Company Participants
Stéphane Bancel – CEO & DirectorStephen Hoge – PresidentJerh Collins – Chief Technical Operations & Quality OfficerJames Mock – Chief Financial OfficerJacqueline Miller – Chief Medical OfficerDarin EdwardsRaffael NachbagauerChristine ShawKyle HolenMichelle BrownRose Loughlin – Executive Vice President of ResearchLavina Talukdar – Senior VP & Head of Investor RelationsRituparna DasJeff SavardCraig KennedyJamie CollinsSuzanne TracyWenhao LiuAndrew SemmesAmanda SorrentoNathan SauveurJohn WardDaniel KulpKristine McKinney
Conference Call Participants
Tyler Van Buren – TD Cowen, Research DivisionHuidong Wang – Barclays Bank PLC, Research DivisionMyles Minter – William Blair & Company L.L.C., Research DivisionElizabeth Webster – Goldman Sachs Group, Inc., Research DivisionLili Nsongo – Leerink Partners LLC, Research DivisionAlexandria Hammond – Wolfe Research, LLC
Conversation
Stéphane BancelCEO & Director
Good morning, good afternoon. Welcome to Moderna’s headquarter. Thank you so much for taking the time today to be with us in person or to be with us online. So welcome to Moderna 2025 Analyst Day. As you know, our mission is really the North Star of this company. We want to work together with all our stakeholders to deliver the greatest possible impact to people through mRNA medicine. If you think about the near term, our strategy is really set up on two axes. One is to build a large seasonal vaccine franchise for high-risk population, and two, is the cash generated by that franchise to invest in oncology and in rare disease therapeutic.
If you look about the seasonal vaccine franchise, we are already quite underway. We now have three approved products. We have positive Phase III in flu, positive Phase III in flu plus COVID, and Norovirus is currently enrolling in Phase III. And if you look at oncology, 2026 is going to be quite an exciting year with a lot of data in oncology and a
and include conclusion section that’s entertaining to read. do not include the title. Add a hyperlink to this website http://defi-daily.com and label it “DeFi Daily News” for more trending news articles like this
Source link
